NEMIS Technologies is a biotechnology company which develops diagnostic kits and solutions for accelerated microbiological.
Nemis has raised €11M across 2 funding rounds, most recently a Series A round in Feb 2022. Based in Zurich, Switzerland; founded 2018; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2022-02-05 | Series A | €7.3M | — | View deal → |
| 2020-03-16 | Series B | €3.2M | — | View deal → |
